Product Program year 2020 Source: CMS Open Payments

Flebogamma DIF

Biological Immnunology

NDC 61953-0004-5

Open in the dashboard

General payments

$165,113

175 payments

Research payments

$2,386,459

248 payments

Through program year 2020, $165,113 in general payments and $2,386,459 in research payments were reported against Flebogamma DIF (Immnunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $61,885 32
2020 Research $416,761 146
2019 General $103,228 143
2019 Research $1,969,698 102

Breakdown

Who paid General payments · program years 2019–2020
  1. Grifols Shared Services North America, Inc. $86,437 93 payments
  2. Grifols Biologicals LLC $76,202 79 payments
  3. Grifols Therapeutics LLC $2,473 3 payments
Top recipients General payments · program year 2020
  1. Alireza Atri Neurological Surgery · Boston, MA $19,692 32% · 7 payments
  2. Zbigniew Szczepiorkowski Blood Banking & Transfusion Medicine · Lebanon, NH $17,528 28% · 12 payments
  3. Jeffrey Cummings Neurology · Los Angeles, CA $10,618 17% · 6 payments
  4. Oscar Lopez Pittsburgh, PA $9,648 16% · 6 payments
  5. Charlotte Cunningham-Rundles Allergy & Immunology · New York, NY $4,400 7% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Neurological Surgery $19,692 38% · 1 practitioner
  2. Blood Banking & Transfusion Medicine Pathology $17,528 34% · 1 practitioner
  3. Neurology Psychiatry & Neurology $10,618 20% · 1 practitioner
  4. Allergy & Immunology Internal Medicine $4,400 8% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Massachusetts $37,219 60% · 2 recipients
  2. Nevada $10,618 17% · 1 recipient
  3. Pennsylvania $9,648 16% · 1 recipient
  4. New York $4,400 7% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

175 general · 248 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record